 Shares of AngioDynamics NASDAQ:ANGO were unchanged after the company reported Q4 results.Quarterly Results Earnings per share fell 124.00 over the past year to 0.06, which were in line with the estimate of 0.06.Revenue of 58,332,000 declined by 39.43 year over year, which missed the estimate of 64,300,000.Outlook Earnings guidance hasnt been issued by the company for now.AngioDynamics hasnt issued any revenue guidance for the time being.Details Of The Call Date: Jul 16, 2020View more earnings on ANGOTime: 08:00 AMET Webcast URL: Stock Performance Companys 52-week high was at 21.90Companys 52-week low was at 7.48Price action over last quarter: Up 7.39Company Profile AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.See more from Benzinga Earnings Scheduled For July 16, 2020C 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 